Engineering of Immune Checkpoints B7-H3 and CD155 Enhances Immune Compatibility of MHC-I^−/− iPSCs for β Cell Replacement

By profiling the relevant NK-activating ligands on iPSCs during in vitro differentiation into pancreatic β cells, researchers found that they express high levels of B7-H3 and CD155.